Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial

NCT05831202 is registered in ClinicalTrials.gov with Galaxy Therapeutics INC as lead sponsor.

NCT NCT05831202
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05831202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial
Lead sponsor
Galaxy Therapeutics INC
Phase
Phase 3
Overall status
Active, not recruiting
Start date
August 6, 2024
Completion date
September 10, 2030
Enrollment
279 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

intracranial aneurysm